Stockscreener 앱 받기
21.19
3.11%
0.64
전일 마감가:
$20.55
열려 있는:
$20.59
하루 거래량:
342.58K
Relative Volume:
3.26
시가총액:
$736.33M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+5.69%
1개월 성능:
+0.00%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$20.00
$22.20
1주일 범위
$19.65
$25.58
52주 변동 폭
$16.59
$25.58
First Tracks Biotherapeutics Inc Stock (TRAX) Company Profile
Compare TRAX vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TRAX
First Tracks Biotherapeutics Inc
|
21.19 | 736.33M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
First Tracks Biotherapeutics Inc Stock (TRAX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-24 | 개시 | Leerink Partners | Outperform |
| 2026-04-24 | 개시 | Wedbush | Outperform |
| 2026-04-23 | 개시 | JP Morgan | Overweight |
| 2026-04-22 | 개시 | Barclays | Overweight |
| 2026-04-21 | 개시 | UBS | Buy |
First Tracks Biotherapeutics Inc 주식(TRAX)의 최신 뉴스
First Tracks: Huge Cash Reserves Will Not Sustain Testing For Long (TRAX) - Seeking Alpha
This First Tracks Biotherapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Monday - Sahm
First Tracks Price Target Announced at $54.00/Share by Piper Sandler - Moomoo
First Tracks Initiated at Overweight by Piper Sandler - Moomoo
This First Tracks Biotherapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations F - Benzinga
Piper Sandler initiates First Tracks stock with overweight rating By Investing.com - Investing.com Nigeria
Net income of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
First Tracks Biotherapeutics Inc (TRAX) Stock Price, Quote, News & History - Benzinga
TRAX Price History for First Tracks Biotherapeutics Stock - Barchart
Number of employees of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
What is the current Price Target and Forecast for First Tracks Biotherapeutics, Inc. (TRAX) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Earnings Yield (TTM) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Total Assets (Quarterly) - Zacks Investment Research
H.C. Wainwright Initiates First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Announces Target Price $30 - Moomoo
First Tracks Biotherapeutics, Inc. (TRAX) Price To Cash Flow - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Total Expenses (Quarterly) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Revenue (Quarterly) Yoy Growth - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Total Long Term Debt (Quarterly) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Price To Free Cash Flow - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Net Income (Quarterly) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Cash Equivalents (Quarterly) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Total Liabilities - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Free Cash Flow (TTM) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Total Expenses (TTM) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Eps Diluted - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Book Value - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Shareholders Equity (Quarterly) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Free Cash Flow (Quarterly) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Cash From Investing (TTM) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Revenue (TTM) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Enterprise Value - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Gross Profit (TTM) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Gross Margin (TTM) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Revenue (Quarterly) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Cash From Operations (Quarterly) - Zacks Investment Research
First Tracks Biotherapeutics, Inc. (TRAX) Market Cap - Zacks Investment Research
This Micron Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
HC Wainwright Initiates First Tracks Biotherapeutics at Buy - marketscreener.com
H.C. Wainwright initiates First Tracks stock with buy rating By Investing.com - Investing.com Canada
AnaptysBio Completes Spin-Off of First Tracks Biotherapeutics: Key Financial Impacts and Pro Forma Results - Minichart
First Tracks Biotherapeutics, Inc. Financial Statements – NASDAQ:TRAX - TradingView
Price to earnings ratio of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
First Tracks Biotherapeutics, Inc. Statistics – NASDAQ:TRAX - TradingView
First Tracks Biotherapeutics, Inc. Revenue Breakdown – NASDAQ:TRAX - TradingView
Anaptysbio’s spinout First Tracks hits the slopes - BioWorld News
AnaptysBio rises after completing First Tracks spinoff - MSN
Leerink Partners Initiates First Tracks Biotherapeutics(TRAX.US) With Buy Rating, Announces Target Price $46 - Moomoo
First Tracks Biotherapeutics, Inc. Dividends – NASDAQ:TRAX - TradingView
First Tracks Biotherapeutics, Inc. Income Statement – NASDAQ:TRAX - TradingView
Basic earnings per share (basic EPS) of First Tracks Biotherapeutics, Inc. – NASDAQ:TRAX - TradingView
First Tracks Biotherapeutics Inc (TRAX) 재무 분석
First Tracks Biotherapeutics Inc (TRAX)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.14%
0.48%
자본화:
|
볼륨(24시간):